208 related articles for article (PubMed ID: 9084801)
21. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
Bower M; Weir J; Francis N; Newsom-Davis T; Powles S; Crook T; Boffito M; Gazzard B; Nelson M
AIDS; 2009 Aug; 23(13):1701-6. PubMed ID: 19550283
[TBL] [Abstract][Full Text] [Related]
22. Impact of opportunistic disease on survival in patients with HIV infection.
Chaisson RE; Gallant JE; Keruly JC; Moore RD
AIDS; 1998 Jan; 12(1):29-33. PubMed ID: 9456252
[TBL] [Abstract][Full Text] [Related]
23. Bronchopulmonary Kaposi's sarcoma in 106 HIV-1 infected patients.
Hannon FB; Easterbrook PJ; Padley S; Boag F; Goodall R; Phillips RH
Int J STD AIDS; 1998 Sep; 9(9):518-25. PubMed ID: 9764935
[TBL] [Abstract][Full Text] [Related]
24. Interferon lambda 3/4 polymorphisms are associated with AIDS-related Kaposi's sarcoma.
Bibert S; Wójtowicz A; Taffé P; Tarr PE; Bernasconi E; Furrer H; Günthard HF; Hoffmann M; Kaiser L; Osthoff M; Fellay J; Cavassini M; Bochud PY;
AIDS; 2018 Nov; 32(18):2759-2765. PubMed ID: 30234607
[TBL] [Abstract][Full Text] [Related]
25. Presentation and survival of patients with AIDS-related Kaposi's sarcoma in Jos, Nigeria.
Agaba PA; Sule HM; Ojoh RO; Hassan Z; Apena L; Mu'azu MA; Badung B; Agbaji OO; Idoko JA; Kanki P
Int J STD AIDS; 2009 Jun; 20(6):410-3. PubMed ID: 19451327
[TBL] [Abstract][Full Text] [Related]
26. Intrathoracic Kaposi's sarcoma in women with AIDS.
Haramati LB; Wong J
Chest; 2000 Feb; 117(2):410-4. PubMed ID: 10669683
[TBL] [Abstract][Full Text] [Related]
27. Genotypic and clinicopathological characterization of Kaposi's sarcoma-associated herpesvirus infection in Japan.
Kanno T; Sato Y; Nakamura T; Sakamoto K; Sata T; Katano H
J Med Virol; 2010 Mar; 82(3):400-6. PubMed ID: 20087946
[TBL] [Abstract][Full Text] [Related]
28. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.
Mocroft A; Youle M; Gazzard B; Morcinek J; Halai R; Phillips AN
AIDS; 1996 Sep; 10(10):1101-5. PubMed ID: 8874626
[TBL] [Abstract][Full Text] [Related]
29. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.
Pellet C; Chevret S; Blum L; Gauvillé C; Hurault M; Blanchard G; Agbalika F; Lascoux C; Ponscarme D; Morel P; Calvo F; Lebbé C
J Invest Dermatol; 2001 Oct; 117(4):858-63. PubMed ID: 11676823
[TBL] [Abstract][Full Text] [Related]
30. Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS Clinical Trial Group study participants.
Rabkin CS; Testa MA; Huang J; Von Roenn JH
J Acquir Immune Defic Syndr; 1999 Aug; 21 Suppl 1():S31-3. PubMed ID: 10430216
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
[TBL] [Abstract][Full Text] [Related]
32. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and associated risk factors for Kaposi's sarcoma among HIV-positive patients in a referral hospital in Northern Tanzania: a retrospective hospital-based study.
Semango GP; Charles RM; Swai CI; Mremi A; Amsi P; Sonda T; Shao ER; Mavura DR; Joosten LAB; Sauli E; Nyindo M
BMC Cancer; 2018 Dec; 18(1):1258. PubMed ID: 30558571
[TBL] [Abstract][Full Text] [Related]
34. Is Kaposi's sarcoma occurring at higher CD4 cell counts over the course of the HIV epidemic?
Crum-Cianflone NF; Hullsiek KH; Ganesan A; Weintrob A; Okulicz JF; Agan BK;
AIDS; 2010 Nov; 24(18):2881-3. PubMed ID: 20827160
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of Kaposi's sarcoma.
Beral V
Cancer Surv; 1991; 10():5-22. PubMed ID: 1821323
[TBL] [Abstract][Full Text] [Related]
36. Kaposi's sarcoma: a reevaluation.
Orfanos CE; Husak R; Wölfer U; Garbe C
Recent Results Cancer Res; 1995; 139():275-96. PubMed ID: 7541146
[TBL] [Abstract][Full Text] [Related]
37. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.
International Collaboration on HIV and Cancer
J Natl Cancer Inst; 2000 Nov; 92(22):1823-30. PubMed ID: 11078759
[TBL] [Abstract][Full Text] [Related]
38. Declining incidence and later occurrence of Kaposi's sarcoma among persons with AIDS in Australia: the Australian AIDS cohort.
Dore GJ; Li Y; Grulich AE; Hoy JF; Mallal SA; Mijch AM; French MA; Cooper DA; Kaldor JM
AIDS; 1996 Oct; 10(12):1401-6. PubMed ID: 8902070
[TBL] [Abstract][Full Text] [Related]
39. [Kaposi's sarcoma during HIV infection in Morocco (apropos of 50 cases)].
Chakib A; Hliwa W; Marih L; Himmich H
Bull Soc Pathol Exot; 2003 May; 96(2):86-9. PubMed ID: 12836521
[TBL] [Abstract][Full Text] [Related]
40. Epidemiologic analysis of Kaposi's sarcoma as an early and later AIDS outcome in homosexual men.
Hoover DR; Black C; Jacobson LP; Martínez-Maza O; Seminara D; Saah A; Von Roenn J; Anderson R; Armenian HK
Am J Epidemiol; 1993 Aug; 138(4):266-78. PubMed ID: 8356967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
